After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a ...
The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
A new survey from SiriusXM Media details the issues that many people have with the current state of TV drug ads—and ...
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga ...
While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoimmune indications, not every ...
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback